Oncolytics Biotech® Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer

When viruses heal: Smestad on oncolytic virotherapy

Before scientists could safely engineer viruses for treatment, researchers in the 1940s and ’50s injected unaltered wild-type viruses into critically ill patients. “It was like the Wild West,” said John Smestad, MD, PhD, third-year Hematology & Medical Oncology fellow. “Doctors would come back with a sample of a virus from a patient who got ill […]

Oncolytics Biotech® Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer

Oncolytics Biotech®, Inc. announced alignment with the US FDA regarding the design of its pivotal study of pelareorep in combination with standard-of-care therapy for the first-line treatment of metastatic pancreatic ductal adenocarcinoma. [Oncolytics Biotech®, Inc.] Press Release